nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TOP2A—Epirubicin—liver cancer	0.468	0.559	CbGbCtD
Podofilox—TOP2A—Doxorubicin—liver cancer	0.249	0.297	CbGbCtD
Podofilox—CYP2C19—Sorafenib—liver cancer	0.0679	0.0811	CbGbCtD
Podofilox—CYP3A4—Sorafenib—liver cancer	0.0328	0.0392	CbGbCtD
Podofilox—CYP3A4—Doxorubicin—liver cancer	0.0199	0.0238	CbGbCtD
Podofilox—Etoposide—GSTP1—liver cancer	0.00468	0.661	CrCbGaD
Podofilox—Etoposide—CYP2E1—liver cancer	0.0024	0.339	CrCbGaD
Podofilox—TOP2A—Doxorubicin—Epirubicin—liver cancer	0.00118	0.173	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—liver cancer	0.00118	0.173	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—liver cancer	0.00118	0.173	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—liver cancer	0.00109	0.16	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—liver cancer	0.00109	0.16	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—liver cancer	0.00109	0.16	CbGdCrCtD
Podofilox—Skin exfoliation—Sorafenib—liver cancer	0.000506	0.0534	CcSEcCtD
Podofilox—Dry skin—Sorafenib—liver cancer	0.000353	0.0372	CcSEcCtD
Podofilox—Redness—Epirubicin—liver cancer	0.00029	0.0306	CcSEcCtD
Podofilox—Blister—Epirubicin—liver cancer	0.000272	0.0287	CcSEcCtD
Podofilox—Redness—Doxorubicin—liver cancer	0.000269	0.0283	CcSEcCtD
Podofilox—Haemoglobin—Sorafenib—liver cancer	0.000268	0.0282	CcSEcCtD
Podofilox—Haemorrhage—Sorafenib—liver cancer	0.000266	0.0281	CcSEcCtD
Podofilox—Skin ulcer—Epirubicin—liver cancer	0.000252	0.0265	CcSEcCtD
Podofilox—Blister—Doxorubicin—liver cancer	0.000252	0.0265	CcSEcCtD
Podofilox—Stinging—Epirubicin—liver cancer	0.000242	0.0255	CcSEcCtD
Podofilox—Immune system disorder—Sorafenib—liver cancer	0.000241	0.0254	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—liver cancer	0.000233	0.0246	CcSEcCtD
Podofilox—Erythema—Sorafenib—liver cancer	0.000232	0.0244	CcSEcCtD
Podofilox—Stinging—Doxorubicin—liver cancer	0.000224	0.0236	CcSEcCtD
Podofilox—Skin discolouration—Epirubicin—liver cancer	0.000217	0.0229	CcSEcCtD
Podofilox—Ulcer—Epirubicin—liver cancer	0.000207	0.0219	CcSEcCtD
Podofilox—Inflammation—Epirubicin—liver cancer	0.000202	0.0213	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—liver cancer	0.000201	0.0212	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000196	0.0207	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—liver cancer	0.000192	0.0202	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—liver cancer	0.000187	0.0197	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—liver cancer	0.000187	0.0197	CcSEcCtD
Podofilox—Skin disorder—Sorafenib—liver cancer	0.000184	0.0194	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—liver cancer	0.000173	0.0183	CcSEcCtD
Podofilox—Pain—Sorafenib—liver cancer	0.000162	0.0171	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.000162	0.00116	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—liver cancer	0.000161	0.00116	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—H2AFX—liver cancer	0.000159	0.00114	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000159	0.00114	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000158	0.00114	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—F2—liver cancer	0.000158	0.00113	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—PPARG—liver cancer	0.000158	0.00113	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.000157	0.00113	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—HPGDS—liver cancer	0.000157	0.00113	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000154	0.0011	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.000153	0.0011	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000153	0.0011	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CG—liver cancer	0.000151	0.00109	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.000151	0.00108	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PCNA—liver cancer	0.000149	0.00107	CbGpPWpGaD
Podofilox—Dermatitis bullous—Epirubicin—liver cancer	0.000149	0.0157	CcSEcCtD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000148	0.00107	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.000148	0.00106	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.000147	0.00106	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000145	0.00104	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000145	0.00104	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TERT—liver cancer	0.000144	0.00103	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—liver cancer	0.000142	0.00102	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000142	0.00102	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000141	0.00101	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000141	0.00101	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000139	0.000996	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000138	0.000992	CbGpPWpGaD
Podofilox—Dermatitis bullous—Doxorubicin—liver cancer	0.000138	0.0145	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	0.000137	0.000984	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000137	0.000982	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000135	0.000966	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000134	0.000964	CbGpPWpGaD
Podofilox—Pruritus—Sorafenib—liver cancer	0.000134	0.0141	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000133	0.000956	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CD—liver cancer	0.000133	0.000954	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.000133	0.000953	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SERPINE1—liver cancer	0.000131	0.000944	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000131	0.000943	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ALB—liver cancer	0.000131	0.000942	CbGpPWpGaD
Podofilox—Dry skin—Epirubicin—liver cancer	0.00013	0.0138	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00013	0.000934	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.00013	0.00093	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—JUN—liver cancer	0.000129	0.000925	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000128	0.000921	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP2E1—liver cancer	0.000128	0.000918	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000127	0.000912	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000127	0.000911	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000127	0.000909	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP2E1—liver cancer	0.000126	0.000905	CbGpPWpGaD
Podofilox—Dizziness—Sorafenib—liver cancer	0.000125	0.0132	CcSEcCtD
Podofilox—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000125	0.000898	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000125	0.000894	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—F2—liver cancer	0.000124	0.000892	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000124	0.000888	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—MAPK8—liver cancer	0.000122	0.000875	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000121	0.00087	CbGpPWpGaD
Podofilox—Dry skin—Doxorubicin—liver cancer	0.000121	0.0127	CcSEcCtD
Podofilox—Vomiting—Sorafenib—liver cancer	0.00012	0.0127	CcSEcCtD
Podofilox—Rash—Sorafenib—liver cancer	0.000119	0.0126	CcSEcCtD
Podofilox—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000119	0.000856	CbGpPWpGaD
Podofilox—Dermatitis—Sorafenib—liver cancer	0.000119	0.0126	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—RAF1—liver cancer	0.000119	0.000852	CbGpPWpGaD
Podofilox—Headache—Sorafenib—liver cancer	0.000119	0.0125	CcSEcCtD
Podofilox—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000118	0.000847	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000118	0.000846	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GGT1—liver cancer	0.000117	0.000843	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000117	0.000842	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PCNA—liver cancer	0.000117	0.000837	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000116	0.000835	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—liver cancer	0.000116	0.000832	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CB—liver cancer	0.000116	0.000832	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000115	0.000824	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—liver cancer	0.000112	0.000804	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—H2AFX—liver cancer	0.000111	0.0008	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000111	0.000797	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000111	0.000797	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.00011	0.000791	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—liver cancer	0.000109	0.000786	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000109	0.000779	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000108	0.000775	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000108	0.000773	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000107	0.000767	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—liver cancer	0.000106	0.000764	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000106	0.00076	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—liver cancer	0.000105	0.000757	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—liver cancer	0.000105	0.000757	CbGpPWpGaD
Podofilox—Haematuria—Epirubicin—liver cancer	0.000105	0.011	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—PCNA—liver cancer	0.000104	0.000749	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—liver cancer	0.000104	0.000746	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000104	0.000746	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1B—liver cancer	0.000103	0.000737	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TERT—liver cancer	0.000101	0.000723	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000101	0.000721	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	9.97e-05	0.000716	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	9.96e-05	0.000715	CbGpPWpGaD
Podofilox—Haemoglobin—Epirubicin—liver cancer	9.89e-05	0.0104	CcSEcCtD
Podofilox—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	9.89e-05	0.00071	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—liver cancer	9.85e-05	0.000707	CbGpPWpGaD
Podofilox—Haemorrhage—Epirubicin—liver cancer	9.84e-05	0.0104	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—CCND1—liver cancer	9.79e-05	0.000703	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	9.78e-05	0.000702	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1B—liver cancer	9.76e-05	0.000701	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—liver cancer	9.69e-05	0.000695	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—liver cancer	9.68e-05	0.000695	CbGpPWpGaD
Podofilox—Haematuria—Doxorubicin—liver cancer	9.68e-05	0.0102	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	9.67e-05	0.000694	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	9.6e-05	0.000689	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—liver cancer	9.55e-05	0.000686	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1A—liver cancer	9.47e-05	0.00068	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—HPGDS—liver cancer	9.43e-05	0.000677	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR1H4—liver cancer	9.38e-05	0.000673	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	9.34e-05	0.000671	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—liver cancer	9.31e-05	0.000668	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR1I3—liver cancer	9.22e-05	0.000662	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1A1—liver cancer	9.18e-05	0.000659	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	9.16e-05	0.000658	CbGpPWpGaD
Podofilox—Haemoglobin—Doxorubicin—liver cancer	9.16e-05	0.00965	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—liver cancer	9.11e-05	0.0096	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	9.11e-05	0.000654	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1A1—liver cancer	9.06e-05	0.00065	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—liver cancer	9.04e-05	0.000649	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	9.02e-05	0.000648	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	9.01e-05	0.000647	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1A—liver cancer	9.01e-05	0.000647	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—liver cancer	8.97e-05	0.000644	CbGpPWpGaD
Podofilox—Immune system disorder—Epirubicin—liver cancer	8.89e-05	0.00937	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	8.86e-05	0.000636	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—liver cancer	8.78e-05	0.000631	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1B—liver cancer	8.73e-05	0.000626	CbGpPWpGaD
Podofilox—Erythema—Epirubicin—liver cancer	8.57e-05	0.00903	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—TP53—liver cancer	8.51e-05	0.000611	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	8.45e-05	0.000607	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—liver cancer	8.38e-05	0.000602	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—liver cancer	8.32e-05	0.000598	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—liver cancer	8.3e-05	0.000596	CbGpPWpGaD
Podofilox—Immune system disorder—Doxorubicin—liver cancer	8.23e-05	0.00867	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—liver cancer	8.08e-05	0.00058	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1A—liver cancer	8.05e-05	0.000578	CbGpPWpGaD
Podofilox—Erythema—Doxorubicin—liver cancer	7.93e-05	0.00836	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—MYC—liver cancer	7.85e-05	0.000564	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—liver cancer	7.79e-05	0.000559	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—liver cancer	7.71e-05	0.000553	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—liver cancer	7.69e-05	0.000552	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2E1—liver cancer	7.69e-05	0.000552	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	7.58e-05	0.000544	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	7.48e-05	0.000537	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—liver cancer	7.47e-05	0.000536	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	7.25e-05	0.00764	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	7.24e-05	0.00052	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—liver cancer	7.06e-05	0.000507	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GGT1—liver cancer	7.06e-05	0.000507	CbGpPWpGaD
Podofilox—Oedema—Epirubicin—liver cancer	6.99e-05	0.00737	CcSEcCtD
Podofilox—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	6.97e-05	0.0005	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—liver cancer	6.89e-05	0.000495	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.89e-05	0.000495	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UGDH—liver cancer	6.87e-05	0.000493	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—liver cancer	6.83e-05	0.000491	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1B—liver cancer	6.83e-05	0.00049	CbGpPWpGaD
Podofilox—Skin disorder—Epirubicin—liver cancer	6.79e-05	0.00716	CcSEcCtD
Podofilox—NR3C1—Adipogenesis—IL6—liver cancer	6.76e-05	0.000485	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	6.7e-05	0.00707	CcSEcCtD
Podofilox—TUBB—Cell Cycle—MYC—liver cancer	6.68e-05	0.000479	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—liver cancer	6.54e-05	0.000469	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—liver cancer	6.51e-05	0.000467	CbGpPWpGaD
Podofilox—Oedema—Doxorubicin—liver cancer	6.47e-05	0.00682	CcSEcCtD
Podofilox—CYP2C19—Metabolism—EPT1—liver cancer	6.46e-05	0.000464	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—liver cancer	6.45e-05	0.000463	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HNF4A—liver cancer	6.39e-05	0.000459	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—liver cancer	6.34e-05	0.000455	CbGpPWpGaD
Podofilox—Insomnia—Epirubicin—liver cancer	6.33e-05	0.00667	CcSEcCtD
Podofilox—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	6.32e-05	0.000453	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—liver cancer	6.3e-05	0.000452	CbGpPWpGaD
Podofilox—Skin disorder—Doxorubicin—liver cancer	6.29e-05	0.00663	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—liver cancer	6.28e-05	0.00662	CcSEcCtD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	6.25e-05	0.000449	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TAT—liver cancer	6.12e-05	0.000439	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—liver cancer	6.1e-05	0.000438	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.02e-05	0.000432	CbGpPWpGaD
Podofilox—Pain—Epirubicin—liver cancer	5.98e-05	0.00631	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—liver cancer	5.85e-05	0.00617	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	5.84e-05	0.00042	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.83e-05	0.000418	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—liver cancer	5.82e-05	0.000418	CbGpPWpGaD
Podofilox—Paraesthesia—Doxorubicin—liver cancer	5.81e-05	0.00613	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—AKT1—liver cancer	5.77e-05	0.000414	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	5.76e-05	0.000414	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.75e-05	0.000412	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—liver cancer	5.63e-05	0.000404	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSMD10—liver cancer	5.58e-05	0.000401	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSMA4—liver cancer	5.58e-05	0.000401	CbGpPWpGaD
Podofilox—Pain—Doxorubicin—liver cancer	5.53e-05	0.00583	CcSEcCtD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.52e-05	0.000396	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—liver cancer	5.48e-05	0.000394	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.45e-05	0.000391	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—liver cancer	5.22e-05	0.000375	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	5.19e-05	0.000373	CbGpPWpGaD
Podofilox—Pruritus—Epirubicin—liver cancer	4.95e-05	0.00522	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—MYC—liver cancer	4.67e-05	0.000335	CbGpPWpGaD
Podofilox—Dizziness—Epirubicin—liver cancer	4.63e-05	0.00488	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—liver cancer	4.58e-05	0.00483	CcSEcCtD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.51e-05	0.000324	CbGpPWpGaD
Podofilox—Vomiting—Epirubicin—liver cancer	4.45e-05	0.00469	CcSEcCtD
Podofilox—Rash—Epirubicin—liver cancer	4.41e-05	0.00465	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—liver cancer	4.41e-05	0.00464	CcSEcCtD
Podofilox—Headache—Epirubicin—liver cancer	4.38e-05	0.00462	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—liver cancer	4.28e-05	0.00451	CcSEcCtD
Podofilox—CYP2C19—Metabolism—CPT1B—liver cancer	4.16e-05	0.000299	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GLUL—liver cancer	4.16e-05	0.000299	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UGDH—liver cancer	4.13e-05	0.000297	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—liver cancer	4.11e-05	0.00434	CcSEcCtD
Podofilox—Rash—Doxorubicin—liver cancer	4.08e-05	0.0043	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—liver cancer	4.08e-05	0.0043	CcSEcCtD
Podofilox—Headache—Doxorubicin—liver cancer	4.05e-05	0.00427	CcSEcCtD
Podofilox—CYP2C19—Metabolism—NR1H4—liver cancer	4.01e-05	0.000288	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA3—liver cancer	3.94e-05	0.000283	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—EPT1—liver cancer	3.88e-05	0.000279	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—liver cancer	3.84e-05	0.000275	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—H2AFX—liver cancer	3.77e-05	0.000271	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TAT—liver cancer	3.68e-05	0.000264	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA4—liver cancer	3.61e-05	0.000259	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.53e-05	0.000253	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA2—liver cancer	3.52e-05	0.000252	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA1—liver cancer	3.39e-05	0.000244	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARA—liver cancer	3.36e-05	0.000241	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAT2—liver cancer	3.35e-05	0.000241	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—liver cancer	3.28e-05	0.000236	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.23e-05	0.000232	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDOB—liver cancer	3.22e-05	0.000231	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK14—liver cancer	3.1e-05	0.000223	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CRABP1—liver cancer	3.07e-05	0.00022	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—liver cancer	3.04e-05	0.000218	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—liver cancer	2.77e-05	0.000199	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.76e-05	0.000198	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPGDS—liver cancer	2.68e-05	0.000193	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.67e-05	0.000191	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GLUL—liver cancer	2.5e-05	0.00018	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CPT1B—liver cancer	2.5e-05	0.00018	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SERPINE1—liver cancer	2.5e-05	0.000179	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.43e-05	0.000174	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NR1H4—liver cancer	2.41e-05	0.000173	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.4e-05	0.000172	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSMD10—liver cancer	2.39e-05	0.000172	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSMA4—liver cancer	2.39e-05	0.000172	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA3—liver cancer	2.37e-05	0.00017	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GOT2—liver cancer	2.33e-05	0.000167	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2E1—liver cancer	2.19e-05	0.000157	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA4—liver cancer	2.17e-05	0.000156	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.12e-05	0.000152	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA2—liver cancer	2.11e-05	0.000152	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYCS—liver cancer	2.05e-05	0.000147	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA1—liver cancer	2.04e-05	0.000146	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAT2—liver cancer	2.02e-05	0.000145	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GGT1—liver cancer	2.01e-05	0.000144	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GOT1—liver cancer	2.01e-05	0.000144	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDOB—liver cancer	1.93e-05	0.000139	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CRABP1—liver cancer	1.84e-05	0.000132	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—liver cancer	1.8e-05	0.000129	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—liver cancer	1.78e-05	0.000128	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—liver cancer	1.66e-05	0.000119	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPGDS—liver cancer	1.61e-05	0.000116	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—liver cancer	1.58e-05	0.000114	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—liver cancer	1.57e-05	0.000113	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—liver cancer	1.46e-05	0.000105	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSMA4—liver cancer	1.44e-05	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSMD10—liver cancer	1.44e-05	0.000103	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARA—liver cancer	1.44e-05	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GOT2—liver cancer	1.4e-05	0.0001	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2E1—liver cancer	1.31e-05	9.44e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.29e-05	9.26e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—liver cancer	1.23e-05	8.83e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYCS—liver cancer	1.23e-05	8.83e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GOT1—liver cancer	1.21e-05	8.66e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GGT1—liver cancer	1.21e-05	8.66e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—liver cancer	1.19e-05	8.52e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—liver cancer	1.1e-05	7.87e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—liver cancer	1.08e-05	7.78e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—liver cancer	1.08e-05	7.76e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—liver cancer	1.07e-05	7.68e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—liver cancer	1.07e-05	7.66e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—liver cancer	9.96e-06	7.15e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—liver cancer	9.44e-06	6.78e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—liver cancer	9.43e-06	6.77e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—liver cancer	8.8e-06	6.32e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARA—liver cancer	8.64e-06	6.2e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—liver cancer	7.4e-06	5.31e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—liver cancer	7.14e-06	5.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—liver cancer	6.5e-06	4.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—liver cancer	6.42e-06	4.61e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—liver cancer	5.75e-06	4.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—liver cancer	5.67e-06	4.07e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—liver cancer	4.69e-06	3.37e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—liver cancer	3.46e-06	2.48e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—liver cancer	2.82e-06	2.03e-05	CbGpPWpGaD
